Taysha Gene Therapies (TSHA) Shares Outstanding (Diluted) (2021 - 2026)
Taysha Gene Therapies' Shares Outstanding (Diluted) came in at 369.04 million for Q2 2026, up 23.8% from 297.99 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Taysha Gene Therapies' Shares Outstanding (Diluted) was 319.71 million, up 27.8% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last four years, with a four-year compound annual growth rate of 70.7% (FY2021 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 250.13 million in FY2024 (+115.4%), 116.12 million in FY2023 (+164.2%), 43.95 million in FY2022 (+16.7%) and 37.65 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
- Year-over-year, Shares Outstanding (Diluted) has increased for 17 consecutive quarters, with growth averaging 49.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 7.1% (Q2 2022) to 265.5% (Q1 2024).
- Business Quant data shows TSHA's Shares Outstanding (Diluted) at 366.63 million (Q1 2026), 319.71 million (Q4 2025) and 353.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Taysha Gene Therapies | 1.54 Bn | 1.54 Bn | - | 369.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 369.04 Mn |
| Mar 31, 2026 | 366.63 Mn |
| Dec 31, 2025 | 319.71 Mn |
| Sep 30, 2025 | 353.31 Mn |
| Jun 30, 2025 | 297.99 Mn |
| Mar 31, 2025 | 269.31 Mn |
| Dec 31, 2024 | 250.13 Mn |
| Sep 30, 2024 | 267.82 Mn |
| Jun 30, 2024 | 232.82 Mn |
| Mar 31, 2024 | 231.25 Mn |
| Dec 31, 2023 | 116.12 Mn |
| Sep 30, 2023 | 125.70 Mn |
| Jun 30, 2023 | 64.24 Mn |
| Mar 31, 2023 | 63.26 Mn |
| Dec 31, 2022 | 43.95 Mn |
| Sep 30, 2022 | 40.94 Mn |
| Jun 30, 2022 | 40.14 Mn |
| Mar 31, 2022 | 38.17 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Sep 30, 2021 | 38.00 Mn |
API Access
Taysha Gene Therapies Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();